Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies
Mar Naranjo-Gomez, Jennifer Lambour, Marc Piechaczyk, Mireia Pelegrin
Mar Naranjo-Gomez, Jennifer Lambour, Marc Piechaczyk, Mireia Pelegrin
View: Text | PDF
Research Article Infectious disease Therapeutics

Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies

  • Text
  • PDF
Abstract

Using a mouse retroviral model, we have shown that mAb-based immunotherapy can induce life-long endogenous protective immunity (vaccine-like effects). This observation has potentially important consequences for treating life-threatening human viral infections. Here, we investigated the role of neutrophils in this effect. Neutrophils are innate immunity effector cells with well-established microbe-killing activities that are rapidly mobilized upon infection. They are also emerging as orchestrators of innate and adaptive immunities. However, their immunomodulatory activity during antiviral mAb immunotherapies has never been studied. Our data reveal that neutrophils have an essential role in immunotherapy-induced immune protection of infected mice. Unexpectedly, neutrophils have a limited effect in controlling viral propagation upon passive immunotherapy administration, which is mostly mediated by NK cells. Instead, neutrophils operate as essential inducers of a potent host humoral antiviral response. Thus, neutrophils play an unexpected key role in protective immunity induction by antiviral mAbs. Our work opens approaches to improve antiviral immunotherapies, as it suggests that preserving neutrophil functions and counts might be required for achieving mAb-induced protective immunity.

Authors

Mar Naranjo-Gomez, Jennifer Lambour, Marc Piechaczyk, Mireia Pelegrin

×

Figure 7

Activation of splenic and BM-isolated neutrophils.

Options: View larger image (or click on image) Download as PowerPoint
Activation of splenic and BM-isolated neutrophils.
(A) Expression of CD1...
(A) Expression of CD11b and CD62L. Spleen cells from naive, I/NT, and I/T mice were isolated at day 8 p.i. and were analyzed by flow cytometry for assaying cell surface expression of CD11b and CD62L. The data represent 5 independent experiments, with at least 18 mice per group. Data are expressed as mean ± SEM. (B) Expression and protein release of BAFF and LTα by neutrophils. Neutrophils from naive, I/NT, and I/T mice were sorted from spleens at day 8 p.i. and assessed for cytokine expression or protein release. Cytokine expression (left) was assessed by RT-qPCR normalized to β-actin. The data show fold changes in cytokine expression by neutrophils from I/NT and I/T mice as compared with naive mice and are representative of 3 independent experiments, with 8–10 mice per group. Protein release (right) was assessed by ELISA in supernatants of sorted neutrophils cultured at a density of 2 × 105 cells/well for 24 hours. The data show BAFF and LTα release by neutrophils from I/NT and I/T and are representative of 3 independent experiments, with 8–10 mice per group. The dashed line represents the level of BAFF released by neutrophils sorted from naive mice. No LTα release was detected from neutrophils sorted from naive mice. (C) BAFF and LTα release by BM-isolated neutrophils. BAFF and LTα release was assessed by ELISA in supernatants of neutrophils isolated from BM of naive mice (>95% purity) and cultured for 24 hours in 667 mAb–coated 24-well plates at a density of 2 × 106 cells in 500 μl medium. Experiments were done in the presence and in the absence of the proinflammatory cytokine IFN-γ (100 ng/ml). 667 mAb–noncoated plates were used as control. The data represent 4 independent experiments. Data are expressed as mean ± SEM. Statistical significance was established using a parametric 1-way ANOVA test with a Bonferroni correction (A and C) or a paired Student’s t test (B) (*P < 0.05; **P < 0.01; ***P < 0.001).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts